Ipamorelin (5 mg) – Premium Research Peptide
1. Peptide Overview
Ipamorelin is a selective growth hormone secretagogue (GHS) that stimulates pulsatile GH release without affecting cortisol or prolactin levels. As a pentapeptide, it offers a clean, targeted approach to enhancing natural growth hormone production with minimal side effects.
2. Mechanism of Action
Binds to ghrelin receptors (GHS-R1a) in the pituitary.
Triggers GH release in a physiological, pulse-like manner.
No unwanted hormone spikes (unlike GHRP-6 or Hexarelin).
3. Key Research Benefits
Muscle Growth: Supports lean mass retention & hypertrophy.
Fat Metabolism: Enhances lipolysis & metabolic rate.
Recovery & Repair: Accelerates tissue healing & collagen synthesis.
Anti-Aging: May improve skin quality & sleep patterns.
4. Administration Protocol
Standard Dose: 200–300 mcg, 1–3x daily (pre-bedtime fasted state optimal).
Cycle Length: 8–12 weeks (followed by a 4-week break).
Injection Method: Subcutaneous (best) or intramuscular.
5. Side Effects & Safety
Extremely low toxicity profile.
Rare mild hunger (less than other GHRPs).
No cortisol/prolactin increase (key advantage over GHRP-6).
6. Ideal Stacking Partners
CJC-1295 (with or without DAC): For amplified GH/IGF-1 output.
Tesamorelin: For visceral fat targeting.
HGH Frag 176-191: For focused lipolysis.
7. Product Specifications
Purity: ≥98% (HPLC-verified).
Form: Lyophilized powder (5 mg/vial).
Storage: Stable at 2–8°C (reconstituted solution: refrigerate, use within 7 days).
Disclaimer: This product is sold for laboratory research only. Not for human, veterinary, or diagnostic use. Consult applicable regulations before purchase.
